Effects of Calcium-channel Blocker on Isolated Rat Portal Vein 钙通道阻滞剂对离体大鼠门静脉的作用
Benazepril was given ( 10-20 mg/ d) as an intervention for group A and group B1. Additional calcium-channel antagonist and/ or β-blocker and/ or vasodilator were used for blood pressure control in those two groups. A组和Ⅰ组患者口服贝那普利10~20mg/d,根据血压控制情况加服钙离子拮抗剂和(或)美托洛尔和(或)血管扩张剂。
RESULTS& CONCLUSION: It is proved that calcium-channel blocker, by the use of many years in the clinic, has satisfactory result of decreasing blood pressure; 结果与结论:钙通道阻滞剂经过多年的临床应用,其降压效果已被临床接受;
Nimodipine ( NM) is a dihydropyridine calcium-channel blocker that has been shown to selectively dilate cerebral vessels and increase cerebral blood flow ( CBF) in animals and human. It is clinically applied in cerebral ischemia and hypoxia. 尼莫地平(Nimodipine,NM)是第二代双氢吡啶类钙通道拮抗剂,能选择性扩张脑血管,增加脑血流量,临床上主要用于治疗缺血性脑血管疾患。